2025
SJR Q2
JCR Q3 · 3,2
36 matched articles
SCIE
Journal detail
Immunology Letters
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
0165247818790542
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,038
- Quartile Q2
- H-Index 118
- Cites/doc 3,03
- Docs (3y) 263
- Cites (3y) 814
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 3,2
- 5Y JIF 3,8
- JCI 0,64
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Immunology Q2
- Immunology and Allergy Q2
Areas
- Immunology and Microbiology
- Medicine
WoS categories
- Immunology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 1,038 | 3,2 | 3,8 | 0,64 | Q3 | 118 |
| 2024 | Q2 | Q3 | 0,98 | 2,8 | 3,4 | 0,64 | Q3 | 114 |
| 2023 | Q2 | Q3 | 1,02 | 3,3 | 3,6 | 0,57 | Q3 | 114 |
| 2022 | Q2 | Q2 | 0,866 | 4,4 | 4 | 0,56 | Q3 | 114 |
| 2021 | Q2 | Q3 | 0,869 | 4,2 | 4,1 | 0,6 | Q3 | 114 |
| 2020 | Q2 | Q3 | 1,152 | 3,7 | 3,5 | 0,71 | Q3 | 114 |
| 2019 | Q2 | Q3 | 1,075 | 3,3 | 3 | 0,66 | Q3 | 114 |
| 2018 | — | Q3 | — | 2,6 | 2,7 | 0,61 | Q3 | — |
| 2017 | Q2 | Q3 | 1,168 | 2,4 | 2,7 | 0,62 | Q3 | 114 |
| 2016 | Q2 | Q3 | 1,243 | 2,9 | 2,6 | — | — | 114 |
| 2015 | Q2 | Q3 | 1,234 | 2,5 | 2,5 | — | — | 114 |
| 2014 | Q2 | Q3 | 1,207 | 2,5 | 2,4 | — | — | 114 |
| 2013 | Q2 | Q3 | 1,227 | 2,4 | 2,3 | — | — | 114 |
| 2012 | Q2 | Q3 | 1,159 | 2,3 | 2,6 | — | — | 114 |
| 2011 | Q2 | Q3 | 1,315 | 2,5 | 2,7 | — | — | 114 |
| 2010 | Q1 | Q3 | 1,32 | 2,5 | 2,5 | — | — | 114 |
| 2009 | — | Q2 | — | 2,9 | 2,6 | — | — | — |
| 2008 | — | Q2 | — | 2,9 | 2,4 | — | — | — |
| 2007 | — | Q2 | — | 2,6 | 2,3 | — | — | — |
| 2006 | — | Q3 | — | 2,4 | — | — | — | — |
| 2005 | — | Q3 | — | 2,3 | — | — | — | — |
| 2004 | — | Q2 | — | 2,1 | — | — | — | — |
| 2003 | — | Q3 | — | 1,7 | — | — | — | — |
| 2002 | — | Q3 | — | 1,8 | — | — | — | — |
| 2001 | — | Q2 | — | 2 | — | — | — | — |
| 2000 | — | Q3 | — | 1,5 | — | — | — | — |
| 1999 | — | Q3 | — | 1,5 | — | — | — | — |
| 1998 | — | Q3 | — | 1,5 | — | — | — | — |
| 1997 | — | Q3 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q3 | Q3 | 103/183 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 107/183 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q3 | 95/181 |
| 2022 | IMMUNOLOGY | SCIE | Q2 | Q3 | 77/161 |
| 2021 | IMMUNOLOGY | SCIE | Q3 | Q3 | 91/162 |
| 2020 | IMMUNOLOGY | SCIE | Q3 | Q3 | 97/162 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q3 | 82/159 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q3 | 112/158 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q3 | 104/155 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 85/151 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 90/151 |
| 2014 | IMMUNOLOGY | SCIE | Q3 | — | 84/148 |
| 2013 | IMMUNOLOGY | SCIE | Q3 | — | 93/144 |
| 2012 | IMMUNOLOGY | SCIE | Q3 | — | 93/137 |
| 2011 | IMMUNOLOGY | SCIE | Q3 | — | 85/139 |
| 2010 | IMMUNOLOGY | SCIE | Q3 | — | 77/134 |
| 2009 | IMMUNOLOGY | SCIE | Q2 | — | 58/128 |
| 2008 | IMMUNOLOGY | SCIE | Q2 | — | 55/121 |
| 2007 | IMMUNOLOGY | SCIE | Q2 | — | 59/119 |
| 2006 | IMMUNOLOGY | SCIE | Q3 | — | 65/117 |
| 2005 | IMMUNOLOGY | SCIE | Q3 | — | 58/115 |
| 2004 | IMMUNOLOGY | SCIE | Q2 | — | 55/111 |
| 2003 | IMMUNOLOGY | SCIE | Q3 | — | 70/114 |
| 2002 | IMMUNOLOGY | SCIE | Q3 | — | 62/119 |
| 2001 | IMMUNOLOGY | SCIE | Q2 | — | 56/114 |
| 2000 | IMMUNOLOGY | SCIE | Q3 | — | 73/116 |
| 1999 | IMMUNOLOGY | SCIE | Q3 | — | 71/115 |
| 1998 | IMMUNOLOGY | SCIE | Q3 | — | 66/120 |
| 1997 | IMMUNOLOGY | SCIE | Q3 | — | 74/117 |